Cercar
31/08/2024
Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
Piñana, JL, Giménez, E, Vázquez, L, Marcos, MA, Guerreiro, M, Duarte, R, Pérez, A, de Miguel, C, Espigado, I, González-Vicent, M, Suarez-Lledó, M, García-Cadenas, I, Martino, R, Cedillo, A, Rovira, M, de la Cámara, R, Navarro, D, Solano, C. Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC). Mediterranean Journal of Hematology and Infectious Diseases. 2024; 16(1)DOI:10.4084/MJHID.2024.065. PMID:39258183. IF:1.500(Q3/8D).
24/06/2024
Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies
Fox, ML, García-Cadenas, I, Navarro, V, Martínez, AP, Kara, M, Bazán, IS, Coll, CF, Bailén, R, Bento, L, Parody, R, Esquirol, A, Orti, G, Mussetti, A, Salamero, O, Martino, R, González, AP, Barba, P, Kwon, M, Solano, C, Bosch, F, Valcárcel, D. Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies. BONE MARROW TRANSPLANTATION. 2024; 59(10)DOI:10.1038/s41409-024-02322-2. PMID:38914883. IF:5.200(Q1/1D).
19/06/2024
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy
Pinana, JL, Vazquez, L, Heras, I, Aiello, TF, López-Corral, L, Arroyo, I, Soler-Espejo, E, García-Cadenas, I, Garcia-Gutierrez, V, Aroca, C, Chorao, P, Olave, MT, Lopez-Jimenez, J, Gómez, MA, Arellano, E, Cuesta-Casas, M, Avendano-Pita, A, González-Santillana, C, Hernández-Rivas, JA, Roldán-Perez, A, Mico-Cerdá, M, Guerreiro, M, Morell, J, Rodriguez-Galvez, P, Labrador, J, Campos, D, Cedillo, A, Vidal, CG, Martino, R, Solano, C. Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy. Frontiers in Oncology. 2024; 14DOI:10.3389/fonc.2024.1389345. PMID:39015498. IF:3.300(Q2/4D).
01/05/2024
Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022.
Aerts R, Mehra V, Groll AH, Martino R, Lagrou K, Robin C, Perruccio K, Blijlevens N, Nucci M, Slavin M, Bretagne S, Cordonnier C. Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022.. LANCET INFECTIOUS DISEASES. 2024; 24(5)DOI:10.1016/S1473-3099(23)00495-4. PMID:38134949. IF:31.000(Q1/1D).
01/05/2024
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Drozd-Sokolowska, J, Gras, L, Koster, L, Martino, R, Salas, MQ, Salmenniemi, U, Zudaire, T, Yañez, L, Bellido, M, Collin, M, Kaufmann, M, Kozlowski, P, Poiré, X, Ferra, C, Sampol, A, Wilson, KMO, Cairoli, A, Gedde-Dahl, T, Deconinck, E, Mirabile, M, Suarez, F, Raj, K, van Gelder, M, Yakoub-Agha, I, Tournilhac, O, Mclornan, DP. Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. HAEMATOLOGICA. 2024; 109(5)DOI:10.3324/haematol.2023.284359. PMID:38205539. IF:10.100(Q1/2D).
01/12/2023
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study
Bastos-Oreiro M., Gutierrez A., Iacoboni G., López Corral L., Reguera J.L., Abrisqueta P., Delgado J., Terol M.J., Hernani R., Martínez N., Ortíz V., Bailen R., Gomez-Centurión I., Caballero A., Sanz J., Guerra Domínguez L., Luzardo H., Mussetti A., Jiménez-Ubieto A., Sancho J.M., Sureda A., Pérez A., Barba P., Kwon M., Martín García-Sancho A.. Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study. Transplantation And Cellular Therapy. 2023; 29(12)DOI:10.1016/j.jtct.2023.08.026. PMID:37659694. IF:3.600(Q1/3D).
01/12/2023
Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients
Arqueros, C, Salazar, J, Gallardo, A, Andrés, M, Tibau, A, Bell, OL, Artigas, A, Lasa, A, Cajal, T, Lerma, E, Barnadas, A. Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients. Biomedicines. 2023; 11(12)DOI:10.3390/biomedicines11123231. PMID:38137452. IF:3.900(Q1/3D).
16/11/2023
Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience
Esquirol, A, Cadenas, IG, Novelli, S, Garrido, A, Caballero, AC, Oñate, G, Lopez, J, Redondo, S, Argüello, M, Saavedra, S, Moreno, C, Briones, J, Sierra, J, Martino, R. Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience. ANNALS OF HEMATOLOGY. 2023; 103(1)DOI:10.1007/s00277-023-05530-w. PMID:37971549. IF:3.000(Q2/4D).